1022641-52-6 Usage
Uses
Used in Pharmaceutical Research and Development:
(6-Bromopyridin-3-yl)-methylamine is used as a building block for the synthesis of biologically active molecules and pharmaceutical compounds. Its unique chemical structure and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
(6-Bromopyridin-3-yl)-methylamine is utilized as an intermediate in the production of agrochemicals, which are chemicals specifically designed to benefit crop production and pest control. Its role in this industry highlights its importance in creating effective and targeted solutions for agricultural needs.
Used in Specialty Chemicals Manufacturing:
(6-Bromopyridin-3-yl)-methylamine is also employed in the manufacturing of specialty chemicals, which are chemicals that serve unique purposes in various industries. Its properties and reactivity make it a valuable component in the creation of diverse chemical structures, further emphasizing its significance in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1022641-52-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,2,6,4 and 1 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1022641-52:
(9*1)+(8*0)+(7*2)+(6*2)+(5*6)+(4*4)+(3*1)+(2*5)+(1*2)=96
96 % 10 = 6
So 1022641-52-6 is a valid CAS Registry Number.
1022641-52-6Relevant academic research and scientific papers
HETEROARYL-CARBOXAMIDES AS HISTONE DEMETHYLASE INHIBITORS
-
, (2019/01/04)
The invention relates to heteroaryl-carboxamides as described herein, useful as histone demethyiase inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy, including e.g., in the treatment of cancer.
HETEROARYL-CARBOXYLIC ACIDS AS HISTONE DEMETHYLASE INHIBITORS
-
, (2018/01/17)
The invention relates to heteroaryl-carboxylic acids as described herein, useful as histone demethylase inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy, including e.g., in the treatment of cancer.
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
-
Page/Page column 128, (2014/06/11)
The present invention provides compounds of formula I: [INSERT FORMULA HERE] or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease, such as malaria, caused by a Plasmodium parasite.
